Page last updated: 2024-09-04

vx 497 and triflupromazine

vx 497 has been researched along with triflupromazine in 1 studies

Compound Research Comparison

Studies
(vx 497)
Trials
(vx 497)
Recent Studies (post-2010)
(vx 497)
Studies
(triflupromazine)
Trials
(triflupromazine)
Recent Studies (post-2010) (triflupromazine)
25373861518

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)triflupromazine (IC50)
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)7.4
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)7.4
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)7.4
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)7.4
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)7.4
Pleiotropic ABC efflux transporter of multiple drugsSaccharomyces cerevisiae S288C4.9
CholinesteraseEquus caballus (horse)7.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vx 497 and triflupromazine

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023